Completed

Performance of Wearers of MyDay Sphere Lenses After A Refit With MyDay Energys Lenses for One Week

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Test lens

+ control lens

Device
Who is being recruted

Eye Diseases

+ Myopia

+ Refractive Errors

From 18 to 35 Years
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: April 2018
See protocol details

Summary

Principal SponsorCooperVision, Inc.
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: April 18, 2018

Actual date on which the first participant was enrolled.

This study is a prospective, multi-center, open label, bilateral, daily wear, one week dispensing study comparing performance of wearers of stenfilcon A control contact lenses after refit with test contact lenses.

Official TitlePerformance of Wearers of MyDay Sphere Lenses After A Refit With MyDay Energys Lenses for One Week
NCT03496701
Principal SponsorCooperVision, Inc.
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

77 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 35 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Eye DiseasesMyopiaRefractive Errors

Criteria

Inclusion Criteria: A person is eligible for inclusion in the study if he/she: * Is between 18 and 35 years of age (inclusive) * Has read and signed the informed consent letter * Is willing and anticipated to follow instructions and maintain the appointment schedule * Habitually wears soft spherical contact lenses with a power between -1.00D to -6.00D (inclusive) for a minimum 5 days per week, 10 hours per day and anticipates no difficulty wearing contact lenses for 7 days per week, 10 hours per day. * Habitually wears or is able to be adequately refit into MyDay Sphere lenses * Demonstrates an acceptable fit with the study lenses * Is correctable to a distance visual acuity of 0.20 logMAR (approximately 20/30) or better (in each eye) with the study contact lenses * Uses digital devices, (e.g. computer, tablet, smart phone, iPad), for more than 4 hours a day, 5 days a week. * Manifest cylindrical spectacle refraction does not exceed -0.75DC in either eye * Has clear corneas and no active ocular disease * Has a contact lens refraction that fits within the available parameters of the study lenses. Exclusion Criteria: A person will be excluded from the study if he/she: * Is participating in any concurrent clinical research study * Has a history of not achieving comfortable CL wear (5 days per week; \> 8 hours/day) * Has a systemic condition that, in the opinion of the investigator, may affect the study measures * Is using any systemic or topical medications that in the opinion of the investigator may affect the study measures. * Presents with slit lamp findings or clinically significant anterior segment abnormalities that would contraindicate contact lens wear such as: * Pathological dry eye or associated findings * Significant pterygium, pinguecula, or corneal scars within the visual axis * Neovascularization \> 0.75 mm in from of the limbus * Giant papillary conjunctivitis (GCP) worse than grade 1 * Anterior uveitis or iritis (or history in past year) * Seborrheic eczema of eyelid region, Seborrheic conjunctivitis * History of corneal ulcers or fungal infections * Poor personal hygiene * Has a known history of corneal hypoesthesia (reduced corneal sensitivity) * Has a known sensitivity to the diagnostic pharmaceuticals to be used in the study * Has aphakia, keratoconus or a highly irregular cornea. * Has presbyopia or has dependence on spectacles for near work over the contact lenses. * Has undergone refractive surgery. * Is pregnant, lactating or planning a pregnancy (by verbal communication) at the time of enrollment * Has participated in any other type of eye related clinical or research study within the last 7 days * Is habitually using rewetting/ lubricating eye drops (more than once per day)

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
All subjects will first wear stenfilcon A contact lenses for one week, then refitted with test contact lenses to wear for one week.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 4 locations

Suspended

Eric White, O.D., Inc.

San Diego, United StatesOpen Eric White, O.D., Inc. in Google Maps
Suspended

Golden Optometric Group

Whittier, United States
Suspended

Golden Vision

Sarasota, United States
Suspended

Nittany Eye Associates

State College, United States
Completed4 Study Centers